Legato Capital Management LLC Cytokinetics Inc Transaction History

Legato Capital Management LLC

  • $761 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024
BUY
$47.86 - $75.05 $209,626 - $328,719
4,380 New
4,380 $237,000
Q4 2023

Jan 16, 2024
BUY
$26.88 - $83.49 $420,295 - $1.31 Million
15,636 New
15,636 $1.31 Million
Q1 2023

May 25, 2023
SELL
$33.36 - $45.71 $96,643 - $132,421
-2,897 Reduced 17.11%
14,038 $493,000
Q4 2022

Feb 01, 2023
BUY
$35.77 - $51.11 $605,764 - $865,547
16,935 New
16,935 $775,000

Others Institutions Holding CYTK

# of Institutions
410
Shares Held
125M
Call Options Held
4.6M
Put Options Held
2.43M
View Full List

About CYTOKINETICS INC

CYTK Quotes by TradingView
  • Ticker CYTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 94,144,096
  • Market Cap $4.92B
  • Description
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...
More about CYTK
Track This Portfolio

Track Legato Capital Management LLC Portfolio

Follow Legato Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legato Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Legato Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email